Skip to content
Search
Taymour Tamaddon, CFA® Co-Portfolio Manager

Taymour Tamaddon is co-portfolio manager of the US Large-Cap Growth Equity Strategy in the Global Equity Division. He is a vice president and a member of the Investment Advisory Committees for the Health Sciences Equity, Global Growth Equity, US Growth Stock Equity, and Global Focused Growth Equity Strategies. In addition, he is a member of the firm’s Equity Steering Committee. Taymour is an executive vice president of the T. Rowe Price Equity Funds, Inc., and a vice president of the T. Rowe Price International Funds, Inc., and T. Rowe Price Global Funds, Inc. He is a vice president of T. Rowe Price Group, Inc., and T. Rowe Price Trust Company.

Years at T.Rowe Price
21
Years of investment experience
22
Accreditations
B.S., Cornell University

Taymour-Tamaddon

8 results

Open

Audience for the document: Share Class: Language of the document:
Open Cancel

Open

Share Class: Language of the document:
Open Cancel
Sign in to manage subscriptions for products, insights and email updates.
Continue with sign in?
To complete sign in and be redirected to your registered country, please select continue. Select cancel to remain on the current site.
Continue Cancel
Once registered, you'll be able to start subscribing.

Change Details

If you need to change your email address please contact us.
Subscriptions
OK
You are ready to start subscribing.
Get started by going to our products or insights section to follow what you're interested in.

Products Insights

GIPS® Information

T. Rowe Price (“TRP”) claims compliance with the Global Investment Performance Standards (GIPS®).

A complete list and description of the Firm's composites and/or a presentation that adheres to the GIPS® standards are available upon request. Additional information regarding the firm's policies and procedures for calculating and reporting performance results is available upon request

Other Literature

You have successfully subscribed.

Notify me by email when
regular data and commentary is available
exceptional commentary is available
new articles become available

Thank you for your continued interest